News Reduction of share capital Please read the full announcement in the attached PDF Attachment 2022_12_Reduction_of_share_capital Continue Reading Previous FibroGen Announces Completion of Patient Enrollment in ZEPHYRUS-1, a Phase 3 Clinical Study of Pamrevlumab in Idiopathic Pulmonary FibrosisNext Otonomy Reports Positive Top-Line Results from Phase 2a Clinical Trial of OTO-413 in Patients with Hearing Loss Related Stories News Trust Stamp announces allowance by the United States Patent and Trademark Office (“USPTO”) of a Non-Provisional Patent Application in respect of technology designed to identify deep fake and other Generative AI fuelled attacks in identity authentication processes News Snail Games Highlights Portfolio Momentum Following Rebel Engine’s Strong Steam Next Fest Performance News Kaltura Launches First-of-Its-Kind AI Accessibility Agent To Ensure Title II Compliance for Educational Institutions News Global Media First Drive of G700: A Comprehensive Validation of GAIA Hybrid Off-Road Architecture News Scandium International Mining Announces Exercise of Options by Chief Executive Officer and Chief Financial Officer News Universal Digital Announces Financing of up to $50 Million Aggregate Principal Amount of Convertible Debentures
